Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has C Probert's publication output changed over time?
ScholarIQpublication output · 1993–2024
Output grew0% over the shown period — from 1 works in 1993 to 1 in 2024.
1
1
1
1
1
1
1
1
1
1
1993199620032006200720132014201720222024
What are the most-cited papers on C Probert?
ScholarIQmost cited works
Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease
Maitreyi Raman, Iftikhar Ahmed, Patrick M. Gillevet, C Probert, Norman M. Ratcliffe, Steve Smith, Rosemary Greenwood, Masoumeh Sikaroodi, Victor L. Lam, Pam Crotty, Jennifer Bailey, Robert P. Myers, Kevin P. Rioux
Clinical Gastroenterology and Hepatology. 2013676 CitationsOPEN ACCESS
Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease
Catherine E. Garner, Stephen J. Smith, Ben de Lacy Costello, Paul White, R.C. Spencer, C Probert, Norman M. Ratcliffem
The FASEB Journal. 2007443 CitationsOPEN ACCESS
Intestinal Enteroendocrine Lineage Cells Possess Homeostatic and Injury-Inducible Stem Cell Activity
Kelley S. Yan, Olivier Gevaert, Grace Zheng, Benedict Anchang, C Probert, Kathryn A. Larkin, Paige S. Davies, Zhuan-fen Cheng, John S. Kaddis, Arnold Han, Kelly Roelf, Ruben I. Calderon, Esther Cynn, Xiaoyi Hu, Komal Mandleywala, Julie Wilhelmy, Sue M. Grimes, David C. Corney, Stéphane C. Boutet, Jessica M. Terry, Phillip Belgrader, Solongo B. Ziraldo, Tarjei S. Mikkelsen, Fengchao Wang, Richard J. von Furstenberg, Nicholas R. Smith, Parthasarathy Chandrakesan, Randal May, Mary Ann S. Chrissy, Rajan Jain, Christine A. Cartwright, Joyce C. Niland, Young-Kwon Hong, Jill L. Carrington, David T. Breault, Jonathan A. Epstein, Courtney W. Houchen, John P. Lynch, Martı́n G. Martı́n, Sylvia K. Plevritis, Christina Curtis, Hanlee P. Ji, Linheng Li, Susan Henning, Melissa H. Wong, Calvin J. Kuo
S128124174. 2017378 CitationsOPEN ACCESS
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial
C Probert, S D Hearing, S Schreiber, T Kühbacher, S Ghosh, I D R Arnott, A Forbes
Gut. 2003362 CitationsOPEN ACCESS
A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease
William J. Sandborn, William J. Sandborn, Subrata Ghosh, Julian Panes, Ivana Vranić, Wenjin Wang, Wojciech Niezychowski, Séverine Vermeire, Olivier Dewit, Harald Peeters, Jiřı́ Stehlı́k, Tomáš Vaňásek, David Laharie, Jean Frédéric Colombel, M A Bigard, Márta Varga, Margit Zeher, János Novák, Béla Hunyady, Á Salamon, I Rácz, Paolo Gionchetti, Anna Kohn, Cosimo Prantera, Pieter Stokkers, Maria Słomka, Leszek Paradowski, Tomasz Arłukowicz, L Kuzela, Boris Baricky, Tibor Hlavatý, María Isabel Vera-Muñoz, Julian Panes, Jordi Guardiola, C Probert, JL Shaffer, Mark Fleisher, Ronald Edward Pruitt, William J. Sandborn, William J. Sandborn, John S. Goff, John T. Weber, R. Bell, Andrew Zwick, Alexandra Gutierrez, Robert H. Levine, Stephen Brett Hanauer, Lori Ann Lavelle, Ravindranath Kottoor, Gerald Wayne Dryden, Robert Hardi, David Vaughn Glorioso, Prabhakar Swaroop, Scott D. Lee, Teressa Joan Patrick, Sheldon Scheinert, Charles A. Sninsky, Seymour Katz, Mark D. Noar, Marco Gaspari, Glenn L. Gordon, Thomas A. Dalton, Douglas Edward Homoky, William Ransom Kilgore, Joel A. Levien, Herbert R. Schneider, S. Moola, Frederik Cornelius Kruger, John Wright, Nazimuddin Aboo
Clinical Gastroenterology and Hepatology. 2014301 Citations
Related on ScholarIQ
University of Liverpool
Institution
Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease
Paper
Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease
Paper
Intestinal Enteroendocrine Lineage Cells Possess Homeostatic and Injury-Inducible Stem Cell Activity
Paper
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial
Paper
A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease
Paper